Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Laureate Education
LAUR
$5.16B
| $1.4M | ﹤0.01% |
140,100
-414,200
| -75% | -$4.01M |
|
|
APTS
2377
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $1.39M | ﹤0.01% |
+183,400
| New | +$1.33M |
|
2378
Sprout Social
SPT
$599M
| $1.39M | ﹤0.01% |
+51,600
| New | +$1.13M |
|
|
STCN
2379
DELISTED
Steel Connect, Inc. Common Stock
STCN
| $1.39M | ﹤0.01% |
248,089
+30,347
| +14% | +$181K |
|
|
HPP
2380
Hudson Pacific Properties
HPP
$764M
| $1.39M | ﹤0.01% |
7,886
-187,543
| -96% | -$31.9M |
|
|
GRFS
2381
Grifois
GRFS
$5.34B
| $1.39M | ﹤0.01% |
76,107
-246,928
| -76% | -$4.9M |
|
|
HAPN
2382
Happen Inc
HAPN
$2.27B
| $1.39M | ﹤0.01% |
+305,120
| New | +$1.9M |
|
2383
Oil States International
OIS
$544M
| $1.38M | ﹤0.01% |
290,743
-115,757
| -28% | -$445K |
|
2384
Freeport-McMoran
FCX
$93.3B
| $1.38M | ﹤0.01% |
+119,071
| New | +$1.09M |
|
2385
iShares Core Moderate Allocation ETF
AOM
$1.78B
| $1.38M | ﹤0.01% |
34,500
+26,000
| +306% | +$1M |
|
|
PETQ
2386
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.38M | ﹤0.01% |
+39,500
| New | +$1.11M |
|
2387
Enlivex Ltd
ENLV
$26.4M
| $1.38M | ﹤0.01% |
18,114
+11,781
| +186% | +$945K |
|
|
BLCM
2388
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $1.38M | ﹤0.01% |
185,071
-39,300
| -18% | -$267K |
|
2389
NextCure
NXTC
$37.9M
| $1.37M | ﹤0.01% |
+5,342
| New | +$2.03M |
|
|
PRAH
2390
DELISTED
PRA Health Sciences, Inc.
PRAH
| $1.37M | ﹤0.01% |
+14,100
| New | +$1.31M |
|
|
SPRT
2391
DELISTED
support.com, Inc.
SPRT
| $1.37M | ﹤0.01% |
972,424
-37,706
| -4% | -$50K |
|
2392
Q32 Bio
QTTB
$452M
| $1.37M | ﹤0.01% |
5,011
+2,023
| +68% | +$539K |
|
|
CDOR
2393
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
| $1.37M | ﹤0.01% |
334,196
+6,609
| +2% | +$25.5K |
|
|
NEW
2394
DELISTED
Puxin Limited American Depositary Shares, each representing twenty Ordinary Shares
NEW
| $1.37M | ﹤0.01% |
26,485
+8,433
| +47% | +$474K |
|
2395
Vanguard Information Technology ETF
VGT
$150B
| $1.37M | ﹤0.01% |
+39,200
| New | +$1.22M |
|
2396
NWPX Infrastructure Inc
NWPX
$1.12B
| $1.36M | ﹤0.01% |
54,400
+21,700
| +66% | +$516K |
|
2397
Nicolet Bankshares
NIC
$3.73B
| $1.36M | ﹤0.01% |
24,795
-23,200
| -48% | -$1.25M |
|
2398
Innodata
INOD
$2.09B
| $1.36M | ﹤0.01% |
1,014,930
+61,593
| +6% | +$70.8K |
|
|
PVBC
2399
DELISTED
Provident Bancorp
PVBC
| $1.36M | ﹤0.01% |
172,653
+22,100
| +15% | +$191K |
|
2400
CB Financial Services
CBFV
$188M
| $1.36M | ﹤0.01% |
62,165
+2,167
| +4% | +$48.4K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.